Loading clinical trials...
Loading clinical trials...
The study evaluates the efficacy and safety of allogeneic platelet lysate eye drops in patients with severe ocular graft versus host disease refractory to conventional systemic and local treatments. T...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
St. Petersburg State Pavlov Medical University
NCT07166848 · Chronic Ocular Graft-versus-host Disease
NCT06495307 · Ocular Graft-versus-host Disease
NCT06952114 · Chronic Ocular Graft-versus-host Disease
NCT03990051 · Chronic Ocular Graft-versus-host Disease
NCT04204122 · Ocular Graft-versus-host Disease
First Pavlov State Medical University of St. Petersburg
Saint Petersburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions